Multisensory Stimulation in Dementia.
Effectiveness of a Multisensory Stimulation Intervention on Neuropsychiatric Symptoms in Moderate to Advanced Dementia: a Randomized Controlled Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Dementia is one of the main causes of disability in the elderly. It is characterized by cognitive, functional and social impairment, as well as behavioral changes. Neuropsychiatric symptoms (NPS) are experienced by patients and observed by caregivers during the natural course of dementia. These symptoms, such as apathy, depression and agitation, are a heterogeneous group of noncognitive symptoms and behaviors. When these symptoms are present, it is more likely that the elderly will be institutionalized as the caregivers will be overloaded with demands. Pharmacological treatment presents little efficacy for the adequate control of these symptoms, and nonpharmacological interventions have been recommended as the first line of treatment. Multisensory stimulation (MSS), a nonpharmacological intervention, is one of the possibilities for intervention in people with dementia and NPS. MSS aims to stimulate the five primary senses, namely, hearing, sight, taste, smell and touch, through pleasurable sensory experiences, in a safe and relaxed environment. This work aims to investigate the effects of an MSS protocol in aged people with dementia living in long-term care institutions in Brazil.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedJuly 5, 2019
July 1, 2019
2.5 years
July 1, 2019
July 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Effects on agitation
To measure agitation, the Cohen-Mansfield Agitation Inventory (CMAI) was used. The maximum score was 144 points and a higher score indicated more frequent symptoms
10-20 minutes
Effects on neuropsychiatric symptoms
The frequency and intensity of neuropsychiatric symptoms (NPS) were assessed by the Neuropsychiatric Inventory (NPI). The scale considered 12 domains and the total score (0-144) was calculated by multiplying the frequency (1-4) and the severiity (1-3) of the symptoms. A higher score indicated more severe NPS. Assessment results are presented for the total score and the four neuropsychiatric subsyndromes of the NPI: hyperactivity, psychosis, affective symptoms and apathy.
10-20 minutes
Effects on depression
The Cornell Scale for Depression in Dementia (CSDD) was employed to evaluate depressive symptoms. Each item was scored as zero (absent), one (mild), two (severe), or unable to evaluate, and the total score (0-38) was calculated by adding the item scores. The scale is divided into five subscales: mood-related signs, behavioral disturbance, physical signs, cyclic functions and ideational disturbance. The total score ranged from 0 to 38; a higher score indicated greater levels of depression.
10-20 minutes
Effects on apathy
The Apathy Scale (AS) was used as a measure of apathy symptoms. The maximum score was 42 points, and higher scores indicated greater intensity of these symptoms
5-10 minutes
Secondary Outcomes (1)
Effect on functional status
10-20 minutes
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention group (IG) was submitted to 16 multisensory sessions that followed the protocol.
Control group
NO INTERVENTIONThe control group (CG) received usual care with routine interventions and services in the LTC, such as bath, hygiene care, watching TV and so on.
Interventions
The intervention group (IG) was submitted to 16 individual multisensory stimulation sessions that followed the protocol. In each session, at least two senses are stimulated in a safe, quiet and confidential environment. The sessions lasted 30 minutes and were conducted twice a week, on the same day and time whenever possible. Nonetheless, the session could be interrupted when the participant wished or if the therapist observed that the patient was uncomfortable. A nondirective approach and one-to-one intervention were adopted.
Eligibility Criteria
You may qualify if:
- elderly person;
- moderate or advanced dementia diagnosis (Clinical Dementia Rating (CDR) of 2 or 3);
- score equal to or less than 17 on the Mini-Mental State Examination;
- Formal caregivers involved in the direct care of these elderly patients;
- Formal caregivers did not have holidays during the intervention period.
You may not qualify if:
- profound vision and hearing loss;
- presence of any additional psychiatric or neurological diagnosis (e.g., schizophrenia or intellectual disability);
- plan to relocate to another residence in less than three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Medicine, Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, 30130-000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larissa S Serelli, PhD
Federal University of Minas Gerais
- PRINCIPAL INVESTIGATOR
Marcella G Assis, PhD
Federal University of Minas Gerais
- PRINCIPAL INVESTIGATOR
Paulo Caramelli, MD, PhD
Federal University of Minas Gerais
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The evaluations were performed by a blind investigator.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
July 1, 2019
First Posted
July 5, 2019
Study Start
February 15, 2016
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
July 5, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share